Denmark· DK-28106259819

Amorina

A norgestimate and ethinylestradiol product containing ethinylestradiol, norgestimat, registered in Denmark by Effik. The same ATC class is registered in 7 of our 19 countries.

ATC G03AA11

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedAmorinaATCG03AA11REGISTER NO.DK-28106259819PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Norgestimate and ethinylestradiol is registered in 7 of 19 countries.

Countries holding a registration under ATC G03AA11 (norgestimate and ethinylestradiol), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 4 of them publish a price we can compare per daily dose

Norgestimate and ethinylestradiol · ATC G03AA11

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Ethinylestradiol, NORGESTIMAT
Manufacturer
Effik
Country
Denmark (DK)
ATC code
G03AA11
ATC class
Norgestimate and ethinylestradiol
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106259819

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

31 interactions on record for norgestimate and ethinylestradiol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Norgestimate and ethinylestradiol · interactions on record

31 records

31 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6f4304bb-28a0-4d20-9678-0d754b089864
GET /v1/drugs/6f4304bb-28a0-4d20-9678-0d754b089864?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "tabletter",
  "source": "dkma",
  "strength": "0,250+0,035 mg",
  "auth_role": "CMS",
  "dk_drugid": "28106259819",
  "substance": "Ethinylestradiol, NORGESTIMAT",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "44104"
}

See everything about norgestimate and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.